Gene: RSAD1
Official Full Name: radical S-adenosyl methionine domain containing 1provided by HGNC
Gene Summary: Enables heme binding activity. Predicted to be involved in porphyrin-containing compound biosynthetic process. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14414 | RSAD1 Knockout cell line (HeLa) | Human | RSAD1 | 1:3~1:6 | Negative | Online Inquiry |
KO14415 | RSAD1 Knockout cell line (HCT 116) | Human | RSAD1 | 1:2~1:4 | Negative | Online Inquiry |
KO14416 | RSAD1 Knockout cell line (HEK293) | Human | RSAD1 | 1:3~1:6 | Negative | Online Inquiry |
KO14417 | RSAD1 Knockout cell line (A549) | Human | RSAD1 | 1:3~1:4 | Negative | Online Inquiry |
RSAD1 Gene Knockout Cell Lines are specifically engineered cellular models in which the RSAD1 gene, known for its role in immune response and cellular stress, has been selectively disrupted. These cell lines serve as powerful tools for investigating the function of RSAD1 in various biological contexts. By creating knockout versions of this gene, researchers are afforded a unique opportunity to observe the effects of RSAD1 deficiency on cell behavior, signaling pathways, and overall immune response mechanisms.
The primary function of RSAD1 is to encode a protein involved in antiviral defense and regulation of inflammatory responses. The knockout cell lines allow scientists to dissect the mechanistic roles of RSAD1 in pathophysiological conditions, providing insights into how loss of this gene may influence susceptibility to infectious diseases, autoimmune disorders, and even cancer. Utilizing these knockout models enables the study of gene interactions and the identification of potential therapeutic targets.
Scientifically, these cell lines are invaluable in research settings aimed at unraveling the complexities of immune signaling pathways and their implications in disease. In clinical settings, they may assist in the development of novel treatment strategies that can leverage restored or modulated immune functions.
What sets RSAD1 Gene Knockout Cell Lines apart from conventional models is their precise genetic modification and their readiness for various experimental setups, allowing for high-reproducibility and confidence in results. This specificity reduces the variability often found in studies using wild-type cell lines.
For researchers and clinicians committed to understanding immune dynamics and exploring potential therapeutic interventions, these knockout cell lines represent a critical asset. They provide a robust framework for experimental design, helping to elucidate the multifaceted roles of RSAD1 in health and disease.
Our company is dedicated to providing high-quality, genetically modified cell lines, ensuring that customers have access to cutting-edge tools that empower scientific research and innovation. With a steadfast commitment to excellence and reliability, we are here to support your journey in advancing biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.